sb-Peptide

sb-Peptide

Bordeaux, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

SB-PEPTIDE is a specialized peptide contract research and manufacturing organization (CRO/CMO) offering custom synthesis, catalog products, and analytical services. Its core value proposition centers on rapid turnaround times, complex peptide manufacturing capabilities, and a strong focus on customer satisfaction. The company operates as a B2B service provider, supporting academic, biotech, and pharmaceutical research in areas like neuroscience, immunology, and infectious disease through its peptide tools.

AntibodiesProteomics

Technology Platform

Solid-phase peptide synthesis (SPPS) platform capable of complex modifications (cyclization, biotinylation, fluorescent labeling, conjugation, heavy peptides, PNA). Features proprietary process optimization for a 10-day express synthesis service and comprehensive analytical services (LCMS, sequencing, purification, impurity profiling).

Opportunities

The growing global demand for peptides in therapeutic discovery and research, particularly in complex modified forms for neuroscience, immunology, and oncology, presents a significant opportunity.
The company's express service model addresses a critical need for speed in research, creating a premium offering.
Expansion into GMP manufacturing for clinical-stage peptides could represent a major growth avenue.

Risk Factors

High competition in the peptide CRO/CMO sector from both large multinationals and niche players pressures pricing and service differentiation.
Operational risks include the technical challenges of synthesizing complex peptides reliably and dependence on the R&D spending cycles of academic and biotech clients.
Supply chain volatility for specialty reagents could impact costs and timelines.

Competitive Landscape

SB-PEPTIDE competes in a crowded market with large players like Bachem, GenScript, and Thermo Fisher Scientific, which offer broad portfolios and scale, and numerous smaller specialized CROs. Its competitive edge is its focus on complex, modified peptides, rapid express service, and a strong catalog in neuroscience. Success depends on maintaining technical excellence, customer service, and speed against competitors with potentially greater resources.